DeVinney Erick Wayne, Chief Innovation Officer at Axogen Inc. ($AXGN), sold shares on the open market three times in the last 365 days, totaling about $892 thousand. His most recent sale occurred on December 9, 2025. These sales rank in 5,200th place among 11,678 insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 6363 | $0.00 | 259,297.0000 | 49,088,436 | 2.52% | 0.01% |
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 11575 | $0.00 | 11,575.0000 | 49,088,436 | 9999.99% | 0.02% |
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 6363 | $0.00 | 6,363.0000 | 49,088,436 | 9999.99% | 0.01% |
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 5221 | $32.84 | 262,781.0000 | 49,088,436 | 1.95% | 0.01% |
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 11575 | $0.00 | 268,002.0000 | 49,088,436 | 4.51% | 0.02% |
| March 16, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 2870 | $32.84 | 256,427.0000 | 49,088,436 | 1.11% | 0.01% |
| Feb. 26, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 33780 | $0.00 | 274,912.0000 | 49,088,436 | 14.01% | 0.07% |
| March 1, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 11276 | $30.65 | 252,934.0000 | 49,088,436 | 4.27% | 0.02% |
| Feb. 26, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 10702 | $31.90 | 264,210.0000 | 49,088,436 | 3.89% | 0.02% |
| Feb. 26, 2026 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Restricted Stock Units | 23000 | $0.00 | 23,000.0000 | 49,088,436 | 9999.99% | 0.05% |
| Dec. 9, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 19517 | $31.21 | 241,132.0000 | 49,088,436 | 7.49% | 0.04% |
| Dec. 4, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 40000 | $0.00 | 260,649.0000 | 49,088,436 | 18.13% | 0.08% |
| Sept. 13, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 221,786.0000 | 44,257,754 | 1.14% | 0.01% |
| Sept. 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 1137 | $16.29 | 220,649.0000 | 44,257,754 | 0.51% | 0.00% |
| March 25, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Restricted Stock Units | 38000 | $0.00 | 38,000.0000 | 44,257,754 | 9999.99% | 0.09% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 6362 | $0.00 | 6,363.0000 | 44,257,754 | 50.00% | 0.01% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 2950 | $0.00 | 203,361.0000 | 44,257,754 | 1.47% | 0.01% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 6362 | $0.00 | 209,723.0000 | 44,257,754 | 3.13% | 0.01% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 23150 | $0.00 | 232,873.0000 | 44,257,754 | 11.04% | 0.05% |
| March 19, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 15111 | $17.50 | 217,762.0000 | 44,257,754 | 6.49% | 0.03% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 2950 | $0.00 | 0.0000 | 44,257,754 | 100.00% | 0.01% |
| March 16, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 23150 | $0.00 | 23,150.0000 | 44,257,754 | 50.00% | 0.05% |
| Feb. 28, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 24799 | $0.00 | 209,301.0000 | 44,257,754 | 13.44% | 0.06% |
| March 4, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 8296 | $18.35 | 201,005.0000 | 44,257,754 | 3.96% | 0.02% |
| Feb. 22, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 185,474.0000 | 44,257,754 | 1.37% | 0.01% |
| Feb. 25, 2025 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 972 | $16.50 | 184,502.0000 | 44,257,754 | 0.52% | 0.00% |
| Sept. 13, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 179,974.0000 | 42,878,543 | 1.41% | 0.01% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 12725 | $0.00 | 180,615.0000 | 42,878,543 | 7.58% | 0.03% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 3000 | $0.00 | 166,377.0000 | 42,878,543 | 1.84% | 0.01% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 2950 | $0.00 | 168,611.0000 | 42,878,543 | 1.78% | 0.01% |
| March 21, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 716 | $7.68 | 165,661.0000 | 42,878,543 | 0.43% | 0.00% |
| March 21, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 721 | $7.68 | 167,890.0000 | 42,878,543 | 0.43% | 0.00% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 12725 | $0.00 | 12,725.0000 | 42,878,543 | 50.00% | 0.03% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 2950 | $0.00 | 2,950.0000 | 42,878,543 | 50.00% | 0.01% |
| March 16, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 3000 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.01% |
| March 21, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 3141 | $7.68 | 177,474.0000 | 42,878,543 | 1.74% | 0.01% |
| March 1, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 50000 | $0.00 | 163,377.0000 | 42,878,543 | 44.10% | 0.12% |
| Feb. 22, 2024 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Performance Stock Units | 68600 | $0.00 | 68,600.0000 | 42,878,543 | 9999.99% | 0.16% |
| Oct. 13, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | D | Common Stock | 864 | $4.04 | 113,377.0000 | 42,083,125 | 0.76% | 0.00% |
| July 18, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Common Stock | 1579 | $0.00 | 114,241.0000 | 42,083,125 | 1.40% | 0.00% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Employee Stock Option (right to purchase) | 64000 | $0.00 | 64,000.0000 | 42,083,125 | 9999.99% | 0.15% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Restricted Stock Units | 46300 | $0.00 | 46,300.0000 | 42,083,125 | 9999.99% | 0.11% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F | Common Stock | 934 | $8.27 | 112,662.0000 | 42,083,125 | 0.82% | 0.00% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F | Common Stock | 1835 | $8.27 | 110,596.0000 | 42,083,125 | 1.63% | 0.00% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Common Stock | 5900 | $0.00 | 112,431.0000 | 42,083,125 | 5.54% | 0.01% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Common Stock | 3000 | $0.00 | 113,596.0000 | 42,083,125 | 2.71% | 0.01% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Restricted Stock Units | 5900 | $0.00 | 5,900.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | Axogen, Inc. | $AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 42,083,125 | 9999.99% | 0.01% |